Clinical Features and Prognostic Factors of Cardiorenal Anemia Syndrome in China: a Retrospective Single-center Study

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2024 Dec 30

PMID 39736509

Authors

Mengyue Zhu

Min Liu

Chunlei Lu

Dafeng He

Jiao Li

Xia Xu

Ying Cui

Chuanyan Zhao

Jun Xu

Gang Zhou

Hongbin Mou

Guangyu Bi

Changhua Liu

Rong Wang

Affiliations

Soon will be listed here.

Abstract

Background: There is little research on cardiorenal anemia syndrome (CRAS) in China. This study was to describe the characteristics of patients with CRAS and to explore risk factors of all-cause death.

Methods: A total of 81,795 patients were hospitalized from August 2012 to August 2021 in the nephrology department and cardiology department, of which 820 patients with CRAS were recruited into this study. The 820 patients were divided into three groups based on New York Heart Association (NYHA) functional class: a NYHA Class II group (n = 124), a NYHA Class III group (n = 492), and a NYHA Class IV group (n = 204). Demographics and laboratory tests were collected and risk factors of all-cause death were analyzed. The primary endpoint of the study was all-cause death.

Results: 820 patients were included, with a median age of 65.00 (51.00-75.00) years and 61.2% were men. The median follow-up was 27.0 (13.0-51.0) months. 416 (50.7%) patients died during follow-up. Age, smoking history, cerebral infarction, NYHA functional class, albumin, serum creatinine (SCr), left ventricular end-diastolic diameter (LVEDD), and left ventricular ejection fraction (LVEF) remained independent predictors of all-cause mortality risk in patients with CRAS (P < 0.05) after adjusting to the potential confounders.

Conclusions: In patients with CRAS, older age, smoking history, and more advanced systolic heart failure and renal failure correlated with worse clinical outcomes at follow-up.

References

Lajoie G, Laszik Z, Nadasdy T, Silva F . The renal-cardiac connection: renal parenchymal alterations in patients with heart disease. Semin Nephrol. 1994; 14(5):441-63. View

Ronco C, Haapio M, House A, Anavekar N, Bellomo R . Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52(19):1527-39. DOI: 10.1016/j.jacc.2008.07.051. View

Palazzuoli A, Gallotta M, Quatrini I, Nuti R . Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag. 2010; 6:411-8. PMC: 2882893. DOI: 10.2147/vhrm.s5789. View

Urena-Torres P, DMarco L, Raggi P, Garcia-Moll X, Brandenburg V, Mazzaferro S . Valvular heart disease and calcification in CKD: more common than appreciated. Nephrol Dial Transplant. 2019; 35(12):2046-2053. DOI: 10.1093/ndt/gfz133. View

Lu K, Kearney L, Hare D, Ord M, Toia D, Jones E . Cardiorenal anemia syndrome as a prognosticator for death in heart failure. Am J Cardiol. 2013; 111(8):1187-91. DOI: 10.1016/j.amjcard.2012.12.049. View

Joseph J, Deedwania P, Acharya T, Aguilar D, Bhatt D, Chyun D . Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. Circulation. 2022; 145(9):e722-e759. DOI: 10.1161/CIR.0000000000001040. View

Owen Jr W, Lew N, Liu Y, Lowrie E, Lazarus J . The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993; 329(14):1001-6. DOI: 10.1056/NEJM199309303291404. View

Candido R, Srivastava P, Cooper M, Burrell L . Diabetes mellitus: a cardiovascular disease. Curr Opin Investig Drugs. 2003; 4(9):1088-94. View

Mahapatra H, Lalmalsawma R, Singh N, Kumar M, Tiwari S . Cardiorenal syndrome. Iran J Kidney Dis. 2009; 3(2):61-70. View

10.

Silverberg D, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E . The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000; 35(7):1737-44. DOI: 10.1016/s0735-1097(00)00613-6. View

11.

Marcos M, de la Espriella R, Gayan Ordas J, Zegri I, Pomares A, Llacer P . Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry. Curr Heart Fail Rep. 2023; 20(3):157-167. DOI: 10.1007/s11897-023-00598-x. View

12.

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023; 44(37):3627-3639. DOI: 10.1093/eurheartj/ehad195. View

13.

Scrutinio D, Passantino A, Santoro D, Catanzaro R . The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival. Eur J Heart Fail. 2010; 13(1):61-7. DOI: 10.1093/eurjhf/hfq167. View

14.

Pallangyo P, Fredrick F, Bhalia S, Nicholaus P, Kisenge P, Mtinangi B . Cardiorenal Anemia Syndrome and Survival among Heart Failure Patients in Tanzania: A Prospective Cohort Study. BMC Cardiovasc Disord. 2017; 17(1):59. PMC: 5307834. DOI: 10.1186/s12872-017-0497-2. View

15.

Manolis A, Manolis T, Melita H, Mikhailidis D, Manolis A . Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022; 102:24-39. DOI: 10.1016/j.ejim.2022.05.004. View

16.

Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y . Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017; 32(3):475-487. DOI: 10.1093/ndt/gfw452. View

17.

Akirov A, Masri-Iraqi H, Atamna A, Shimon I . Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients. Am J Med. 2017; 130(12):1465.e11-1465.e19. DOI: 10.1016/j.amjmed.2017.07.020. View

18.

Thomas M, Cooper M, Zimmet P . Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2015; 12(2):73-81. DOI: 10.1038/nrneph.2015.173. View

19.

Kim C, Choi I, Park H, Kim T, Kim P, Chang K . Impact of Cardiorenal Anemia Syndrome on Short- and Long-Term Clinical Outcomes in Patients Hospitalized with Heart Failure. Cardiorenal Med. 2016; 6(4):269-78. PMC: 5020385. DOI: 10.1159/000443339. View

20.

Lewis T . A Clinical Lecture ON PAROXYSMAL DYSPNOEA IN CARDIORENAL PATIENTS: WITH SPECIAL REFERENCE TO "CARDIAC" AND "URAEMIC" ASTHMA: Delivered at University College Hospital, London, November 12th, 1913. Br Med J. 2010; 2(2761):1417-20. PMC: 2345902. DOI: 10.1136/bmj.2.2761.1417. View